Literature DB >> 26608917

The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.

Jihye Park1, Robert S Welner2, Mei-Yee Chan3, Logan Troppito3, Philipp B Staber2, Daniel G Tenen2, Catherine T Yan4.   

Abstract

Hypomorphic mutations in the nonhomologous end-joining (NHEJ) DNA repair protein DNA ligase IV (LIG4) lead to immunodeficiency with varying severity. In this study, using a murine knock-in model, we investigated the mechanisms underlying abnormalities in class switch recombination (CSR) associated with the human homozygous Lig4 R278H mutation. Previously, we found that despite the near absence of Lig4 end-ligation activity and severely reduced mature B cell numbers, Lig4(R278H/R278H) (Lig4(R/R)) mice exhibit only a partial CSR block, producing near normal IgG1 and IgE but substantially reduced IgG3, IgG2b, and IgA serum levels. In this study, to address the cause of these abnormalities, we assayed CSR in Lig4(R/R) B cells generated via preassembled IgH and IgK V region exons (HL). This revealed that Lig4(R278H) protein levels while intact exhibited a higher turnover rate during activation of switching to IgG3 and IgG2b, as well as delays in CSR kinetics associated with defective proliferation during activation of switching to IgG1 and IgE. Activated Lig4(R/R)HL B cells consistently accumulated high frequencies of activation-induced cytidine deaminase-dependent IgH locus chromosomal breaks and translocations and were more prone to apoptosis, effects that appeared to be p53-independent, as p53 deficiency did not markedly influence these events. Importantly, NHEJ instead of alternative end-joining (A-EJ) was revealed as the predominant mechanism catalyzing robust CSR. Defective CSR was linked to failed NHEJ and residual A-EJ access to unrepaired double-strand breaks. These data firmly demonstrate that Lig4(R278H) activity renders NHEJ to be more error-prone, and they predict increased error-prone NHEJ activity and A-EJ suppression as the cause of the defective B lymphopoiesis in Lig4 patients.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26608917      PMCID: PMC4684978          DOI: 10.4049/jimmunol.1403099

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein.

Authors:  Kara R Jones; David A Gewirtz; Steven M Yannone; Shaoming Zhou; David G Schatz; Kristoffer Valerie; Lawrence F Povirk
Journal:  Mol Cancer Ther       Date:  2005-10       Impact factor: 6.261

2.  Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination.

Authors:  Giulia B Celli; Eros Lazzerini Denchi; Titia de Lange
Journal:  Nat Cell Biol       Date:  2006-07-16       Impact factor: 28.824

3.  ATM prevents the persistence and propagation of chromosome breaks in lymphocytes.

Authors:  Elsa Callén; Mila Jankovic; Simone Difilippantonio; Jeremy A Daniel; Hua-Tang Chen; Arkady Celeste; Manuela Pellegrini; Kevin McBride; Danny Wangsa; Andrea L Bredemeyer; Barry P Sleckman; Thomas Ried; Michel Nussenzweig; André Nussenzweig
Journal:  Cell       Date:  2007-06-28       Impact factor: 41.582

4.  A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome.

Authors:  Tawfeg I Ben-Omran; Karen Cerosaletti; Patrick Concannon; Sheila Weitzman; Marjan M Nezarati
Journal:  Am J Med Genet A       Date:  2005-09-01       Impact factor: 2.802

5.  H2AX prevents DNA breaks from progressing to chromosome breaks and translocations.

Authors:  Sonia Franco; Monica Gostissa; Shan Zha; David B Lombard; Michael M Murphy; Ali A Zarrin; Catherine Yan; Suprawee Tepsuporn; Julio C Morales; Melissa M Adams; Zhenkun Lou; Craig H Bassing; John P Manis; Junjie Chen; Phillip B Carpenter; Frederick W Alt
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

6.  Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.

Authors:  Dietke Buck; Despina Moshous; Régina de Chasseval; Yunmei Ma; Françoise le Deist; Marina Cavazzana-Calvo; Alain Fischer; Jean-Laurent Casanova; Michael R Lieber; Jean-Pierre de Villartay
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

7.  A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.

Authors:  Mirjam van der Burg; Lieneke R van Veelen; Nicole S Verkaik; Wouter W Wiegant; Nico G Hartwig; Barbara H Barendregt; Linda Brugmans; Anja Raams; Nicolaas G J Jaspers; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

8.  IgH class switching and translocations use a robust non-classical end-joining pathway.

Authors:  Catherine T Yan; Cristian Boboila; Ellen Kris Souza; Sonia Franco; Thomas R Hickernell; Michael Murphy; Sunil Gumaste; Mark Geyer; Ali A Zarrin; John P Manis; Klaus Rajewsky; Frederick W Alt
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

9.  A severe form of human combined immunodeficiency due to mutations in DNA ligase IV.

Authors:  Anselm Enders; Paul Fisch; Klaus Schwarz; Ulrich Duffner; Ulrich Pannicke; Elisabeth Nikolopoulos; Anke Peters; Marzenna Orlowska-Volk; Detlev Schindler; Wilhelm Friedrich; Barbara Selle; Charlotte Niemeyer; Stephan Ehl
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

10.  Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors.

Authors:  Jin-Hwan Han; Shizuo Akira; Kathryn Calame; Bruce Beutler; Erik Selsing; Thereza Imanishi-Kari
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

View more
  1 in total

1.  Spatiotemporal Gradient of Cortical Neuron Death Contributes to Microcephaly in Knock-In Mouse Model of Ligase 4 Syndrome.

Authors:  Melody P Lun; Morgan L Shannon; Sevgi Keles; Ismail Reisli; Nicole Luche; Douglas Ryan; Kelly Capuder; Luigi D Notarangelo; Maria K Lehtinen
Journal:  Am J Pathol       Date:  2019-09-18       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.